Apex Science & Engineering Balance Sheet Health
Financial Health criteria checks 5/6
Apex Science & Engineering has a total shareholder equity of NT$3.3B and total debt of NT$3.3B, which brings its debt-to-equity ratio to 99.2%. Its total assets and total liabilities are NT$7.6B and NT$4.3B respectively. Apex Science & Engineering's EBIT is NT$221.7M making its interest coverage ratio -11.5. It has cash and short-term investments of NT$239.6M.
Key information
99.2%
Debt to equity ratio
NT$3.32b
Debt
| Interest coverage ratio | -11.5x |
| Cash | NT$239.60m |
| Equity | NT$3.35b |
| Total liabilities | NT$4.28b |
| Total assets | NT$7.63b |
Recent financial health updates
Recent updates
Apex Science & Engineering's (TWSE:3052) Conservative Accounting Might Explain Soft Earnings
Mar 22
Investors Aren't Buying Apex Science & Engineering Corp.'s (TPE:3052) Earnings
Apr 07Apex Science & Engineering Corp.'s (TPE:3052) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Mar 19What Can The Trends At Apex Science & Engineering (TPE:3052) Tell Us About Their Returns?
Feb 26Is It Worth Buying Apex Science & Engineering Corp. (TPE:3052) For Its 4.1% Dividend Yield?
Feb 05
Apex Science & Engineering (TPE:3052) Seems To Use Debt Quite Sensibly
Jan 19Did You Miss Apex Science & Engineering's (TPE:3052) 53% Share Price Gain?
Jan 01Is Apex Science & Engineering Corp.'s (TPE:3052) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Dec 14Should You Use Apex Science & Engineering's (TPE:3052) Statutory Earnings To Analyse It?
Nov 26Financial Position Analysis
Short Term Liabilities: 3052's short term assets (NT$7.0B) exceed its short term liabilities (NT$3.7B).
Long Term Liabilities: 3052's short term assets (NT$7.0B) exceed its long term liabilities (NT$582.7M).
Debt to Equity History and Analysis
Debt Level: 3052's net debt to equity ratio (92.1%) is considered high.
Reducing Debt: 3052's debt to equity ratio has reduced from 201.2% to 99.2% over the past 5 years.
Debt Coverage: 3052's debt is well covered by operating cash flow (37.2%).
Interest Coverage: 3052 earns more interest than it pays, so coverage of interest payments is not a concern.